Pathomics Health Expands Its Laboratory Operations Into Singapore

0
  • Pathomics Health sets up its clinical diagnostics and research facilities in Singapore, focusing on Infectious Diseases and Oncology and hereby expanding its operations from Malaysia.
  • Pathomics Health will support the acceleration of healthcare and life science research in ASEAN markets by providing outsourcing research testing services in addition to its clinical diagnostics services.

SINGAPORE –

Pathomics Health, a diagnostics and research service provider, focuses on advanced precision diagnostics and digital healthcare solutions. Its full-service CAP (College of American Pathologists) compliant laboratory deploys cutting-edge technologies that are clinically validated by international bodies such as FDA and CE-IVD. Equipped with a multi-disciplinary team of experts, Pathomics Health’s customers and patients receive high-quality diagnostics reports for better management of patient care and health outcomes. In 2017, the University of Malaya and Pathomics Health established GEMS@UM, a public-private partnership, to provide patients access to cost-effective precision medicine. In 2019, Pathomics Health established its regional headquarters in Singapore. In 2022, Pathomics Health is expanding its laboratory operations from Malaysia to Singapore.

For more information on Pathomics Health, visit website at www.pathomicshealth.com.

#pathomicshealth #nextgenerationsequencing #NGS #genomics #covidtesting #covid19 #covid19updates #covidtest #covid #diagnostics #oncology #infectiousdiseases #tuberculosis #latenttuberculosis #latentTB #healthtech #deeptech #coronavirus #qiagen #quantiferon #QFTPLUS #dukenus #leonghoenam #rophiclinic #jenniferteo #singapore

The issuer is solely responsible for the content of this announcement.